JP2003144177A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003144177A5 JP2003144177A5 JP2002083277A JP2002083277A JP2003144177A5 JP 2003144177 A5 JP2003144177 A5 JP 2003144177A5 JP 2002083277 A JP2002083277 A JP 2002083277A JP 2002083277 A JP2002083277 A JP 2002083277A JP 2003144177 A5 JP2003144177 A5 JP 2003144177A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- salt
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 claims 35
- 102000004169 proteins and genes Human genes 0.000 claims 35
- 150000003839 salts Chemical class 0.000 claims 33
- 125000003275 alpha amino acid group Chemical group 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 15
- 102000040430 polynucleotide Human genes 0.000 claims 15
- 108091033319 polynucleotide Proteins 0.000 claims 15
- 239000002157 polynucleotide Substances 0.000 claims 15
- 230000014509 gene expression Effects 0.000 claims 10
- 238000012216 screening Methods 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 4
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002083277A JP2003144177A (ja) | 2001-03-26 | 2002-03-25 | 新規タンパク質、そのｄｎａおよびその用途 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001088041 | 2001-03-26 | ||
| JP2001-88041 | 2001-03-26 | ||
| JP2001258443 | 2001-08-28 | ||
| JP2001-258443 | 2001-08-28 | ||
| JP2002083277A JP2003144177A (ja) | 2001-03-26 | 2002-03-25 | 新規タンパク質、そのｄｎａおよびその用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003144177A JP2003144177A (ja) | 2003-05-20 |
| JP2003144177A5 true JP2003144177A5 (enExample) | 2005-09-15 |
Family
ID=27346353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002083277A Withdrawn JP2003144177A (ja) | 2001-03-26 | 2002-03-25 | 新規タンパク質、そのｄｎａおよびその用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003144177A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080213759A1 (en) | 2005-01-05 | 2008-09-04 | Shionogi & Co., Ltd. | Novel Angiogenesis Inhibitor |
-
2002
- 2002-03-25 JP JP2002083277A patent/JP2003144177A/ja not_active Withdrawn